Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.

Also called NCT02686398

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 174 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02686398
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02686398. Randomized; no masking; primary purpose prevention. Start 2013-10 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis
Condition
Influenza
Condition
End Stage Renal Failure
Intervention (Biological)
Fluad
Intervention (Biological)
Agrippal
Lead sponsor
Korea University Guro Hospital (class: other)

Record details

Record id
cardio:ct-nct02686398
Content hash
338dd0791cc0b6089b6401828594cb174ba4c4fd2fd770265ec5a891c6ca5432